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ABSTRACT
PURPOSE: To analyze pre-, intra- and immediate postoperative parameters of patients submitted to liver transplantation.
METHODS: Eighty-three consecutive orthotopic liver transplants performed from January 2009 to July 2011 were analyzed. The 
patients were divided into 2 groups: A, survivors (MELD between 9 and 60) and B, non-survivors (MELD between 14 and 40), with 
30.6% of group A patients being CHILD C, 51℅ CHILD B and 18,4℅ CHILD A. In group B ,32.1℅ of the patients were CHILD C, 
42,9℅ CHILD B, and 25℅ CHILD A. All orthotopic liver transplantations were performed using the piggyback technique without a 
portacaval shunt. Systemic arterial pressure and serum ALT and AST levels were determined preoperatively and 5, 60 and 1440 minutes 
after arterial graft revascularization. Serum ALT and AST profiles were evaluated for seven days after surgery.
RESULTS: Systemic arterial blood pressure levels, time of hot and hypothermic ischemia and time of graft implant were statistically 
similar for the two groups (p>0.05). Serum levels (U/L) of ALT and AST at the 5, 60 and 1440 minute time points after arterial 
revascularization of the graft were also similar for the two groups studied, as also were the serum ALT and AST profiles. 
CONCLUSIONS: No statistically significant difference in any of the parameters studied was detected between the two groups. Under 
the conditions of the present study and on the basis of the parameters evaluated, no direct relation was detected between the intraoperative 
period and the type of patient outcome in the two groups studied.                                                                          
Keywords: Liver Transplantation. Transaminases. Blood Pressure.
RESUMO
OBJETIVO: Analisar parâmetros do pré, intra e pós-operatório imediato de pacientes submetidos ao transplante de fígado.
MÉTODOS: Foram analisados 83 transplantes ortotópicos de fígado realizados consecutivamente no período janeiro de 2009 a julho de 
2011. Os pacientes foram dividos em dois grupos: A, survivors (MELD entre 16 e 60), e B, non-survivors (MELD entre 14 e 40) sendo 
que 30,6℅ dos pacientes do grupo A eram CHILD C, 51℅ CHILD B e 18,4℅ CHILD A. No grupo B, 32,1℅ dos pacientes eram CHILD 
C, 42,9℅ CHILD B, e 25℅ CHILD A. Todos os transplantes ortotópicos de fígado foram feitos com a técnica de piggyback sem “shunt” 
porto cava. Foram analisados os valores de pressão arterial sistêmica e os níveis séricos de ALT e AST, no pré-operatório, 5, 60 e 1440 
minutos após revascularização arterial do enxerto. Avaliaram-se os perfis séricos da ALT e AST durante sete dias de pós-operatorio. 
RESULTADOS: Verificou-se que em ambos os grupos, os níveis de pressão arterial sistêmica, os tempos de isquemia normotérmica, 
hipotérmica e de implante do enxerto foram estatisticamente semelhantes (p>0,05). Os níveis séricos (U/L) de ALT e AST nos tempos 
de 5, 60 e 1440 minutos após a revascularização arterial do enxerto também foram semelhantes nos grupos estudados. Os perfis séricos 
da ALT e AST foram semelhantes nos dois grupos estudados. 
CONCLUSÕES: Não se verificou diferença estatisticamente significante entre todos os parâmetros estudados, em ambos os grupos. 
Nas condições do presente estudo, não se verificou relação direta do intra-operatório com o tipo de evolução (outcome) dos pacientes 
nos dois grupos estudados.                                                                          
Descritores: Transplante de Fígado. Transaminases. Pressão Arterial.
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Introduction
Patients with cirrhosis of the liver course with a 
hyperdynamic systemic circulation, manifested by an increased 
cardiac output and decreased peripheral vascular resistance and 
arterial pressure1. These changes intensify with disease progression 
and are reversible with liver transplantation. This surgical 
procedure is highly complex for the treatment of preventable 
diseases such as cirrhosis due to complications of hepatitis B virus 
and hepatitis C virus and alcohol-induced cirrhosis in 80% of 
cases2. Patients submitted to a liver transplant have post-transplant 
5-year  survival rates ranging from 70 to 90%3-5.
Literature reports have shown a relation between 
systemic blood pressure levels and the type of postoperative 
outcome1,4. Patients with low arterial blood pressure, due to the 
systemic vasodilation mentioned above, have a postoperative 
outcome involving greater morbidity and mortality. However, 
the data regarding this association are conflicting among authors, 
suggesting that, in reality, the postoperative complications of 
hypotense patients are due to a set of factors such as prolonged 
times of normothermic and hypothermic ischemia, quality of 
the donor and of graft preservation, presence of comorbidities, 
and stage of liver disease6-9. All of these factors may determine 
ischemia/reperfusion injuries in the recipient’s liver that invariably 
determine different types of postoperative outcome.           
The objective of the present study was to evaluate 
consecutive patients submitted to liver transplantation using 
biochemical exams of easy collection and laboratory determination, 
systemic arterial pressure levels, and surgical times to relate them 
to postoperative outcome.
Methods
We retrospectively analyzed 83 orthotopic liver 
transplants consecutively performed during the period from 
January 2009 to July 2011. The research protocol was approved 
by the Research Ethics Committee of the University Hospital, 
Faculty of Medicine of Ribeirao Preto. The patients were divided 
into 2 groups: A, survivors (MELD between 9 and 60), and B, non-
survivors, (MELD between 14 and 40), with 30.6℅ of group A 
patients being CHILD C, 51.0℅ CHILD B and 18.4℅ CHILD A. 
In group B, 32.1℅ of the patients were CHILD C, 42.9℅ CHILD 
B, and 25.0℅ CHILD A. 78.3% of the patients were males and 
patient age ranged from 12 to 67 years (Table 1). All patients who 
died within the first 30 days after surgery were assigned to the non-
survivor group. All orthotopic liver transplants were performed by 
the piggyback technique without a portacaval shunt. There was no 
intraoperative mortality during the study period. There were no 
cases of hepatic artery thrombosis or primary liver non-function. 
Systolic and diastolic systemic arterial pressure was measured 
approximately six hours before the beginning of surgery for liver 
transplantation and serum ALT and AST10 levels were determined 
preoperatively and 5, 60 and 1440 minutes after arterial graft 
revascularization. Serum ALT and AST profiles were evaluated 
for a period of seven days after surgery. 
Statistical analysis
An unpaired Student t test was used to compare 
differences between demographic and clinical data of patients. 
The values were reported as mean ± standard deviation (SD). The 
level of significance was set at 0.05. All statistical analyses were 
performed using SAS software version 9.2 (SAS Institute Inc., 
Cary, NC, USA).
Results
TABLE 1 – Demographic, clinical and etiologic data of 
patients submitted to ortothopic liver transplantation.
Systolic and diastolic arterial pressure levels were similar for 
the patients of the survivor and non-survivor groups (p>0.05), as 
shown in Figure 1.
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FIGURE 1 - Systolic and diastolic arterial pressure levels in patients of 
the survivors and non-survivors groups.
Aminotransferase (ALT and AST) levels at 5, 60 and 
1440 minutes after revascularization were similar (p>0.05), as 
shown in Figure 2. There was no significant difference between 
the survivor and non-survivor groups (p>0.05)
FIGURE 2 - Aminotransferase values, ALT (panel A) and AST (panel B), 
at 5, 60 and 1440 minutes after arterial graft revascularization of patients 
of the survivor and non-survivor groups.
The Time of implant (minutes) was similar for the 
survivor and non- survivor groups (p>0.05) as shown in Figure 3. 
FIGURE 3 - Implant times for the patients of the survivor and non-
survivor groups.
As shown in Figure 4, the times of normothermic 
ischemia (panel A) and hypothermic ischemia (panel B) were 
similar for the survivor and non-survivor groups (p>0.05).   
FIGURE 4 - Normothermic (panel A) and hypothermic (panel B) time 
for the patients of the survivor and non-survivor groups.
The serum aminotransferase profile, ALT (panel A) and 
AST (panel B), determined preoperatively and for seven days 
postoperatively was similar in the survivor and non-survivor 
groups (p>0.05), as shown in Figure 5.
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FIGURE 5 - Aminotransferase values, ALT (panel A) and AST (panel 
B), determined preoperatively and for seven days postoperatively were 
similar for the survivor and non-survivor groups.
Discussion
End-stage liver disease is one of the greatest public 
health problems all over the world. Cirrhosis is the main cause of 
indication of orthotopic liver transplantation (OLT) among adults, 
the most frequent etiologies being alcoholism and chronic hepatitis 
virus A and hepatitis virus B infection. With the refinements 
of the surgical technique, of intensive care and of the clinical 
management of continuous immunosuppression, patient survival 
tends to improve every year5,11-13. 
OLT has a significant preoperative risk and the success of 
the procedure is due in part to appropriate selection of recipients 
from a medical, psychological and social viewpoint, to insure 
perfect patient adherence to the available medical care13,14. 
Due to the severity of the disease and the scarcity of 
organs available for transplantation, especially in Brazil, many 
patients become worse or even die while on the waiting line. The 
ones who succeed in achieving transplantation invariably present 
more severe disease and therefore are likely to experience a higher 
rate of complications during the postoperative period15,16. 
OLT has two basic objectives in the treatment of chronic 
liver disease: to prolong survival and to improve the quality 
of life of the patient, which gradually deteriorates due to the 
complications of the disease, such as ascites, upper digestive 
hemorrhage, encephalopathy, malnutrition, infection and so on. 
Based on the Child-Turcot Pugh (CTP) classification, it can be 
seen that the scores of patients on the waiting list increase while 
they wait for OLT713-15.
Ideally, a liver transplant should be performed before 
the patients experience successive complications. However, the 
opportunity of OLT is difficult and the patients reach the time of 
operation in a much more serious situation than when they entered 
the waiting list. There still is no way to assess with precision the 
functional reserve of a cirrhotic liver or to predict the chances of 
survival of a recipient of a liver transplant. Several studies have 
been conducted in an attempt to find indicators that predict death 
or survival after OLT4,13,15. However, current indexes are unable to 
accurately predict which patients will have a high probability of 
posttransplant survival. For this reason, the search for a prognostic 
factor to predict early mortality of patients submitted to OLT still 
continues.
In the present study, we analyzed 86 consecutive 
transplants performed at a tertiary reference hospital over a 
period of approximately two years. The patients were divided into 
two groups, i.e., survivors and non-survivors. Two biochemical 
and clinical parameters of easy execution and of low cost were 
evaluated in order to determine eventual differences between 
groups.
Systolic and diastolic pressure levels were similar for the 
survivor and non-survivor groups. The arterial pressure considered 
was that measured at the time of patient admission, on average six 
hours before the anesthetic procedure for the transplant. It should 
be pointed out that the systemic pressure levels of the two groups 
were similar to normal values, also considering that all patients 
were chronically taking a beta-blocker in order to reduce portal 
pressure while waiting on the transplant line. These patients are 
known to have peripheral systemic vasodilation and increased 
cardiac output in a compensatory manner, a fact that seems to have 
been effective in these patients6,17,18. 
The times of normal and hypothermic ischemia were 
similar for survivors and non-survivors, demonstrating that these 
times did not interfere significantly in the postoperative course. 
Prolonged times of ischemia, especially normothermic ischemia, 
are known to induce serious postoperative complications that may 
contribute directly or indirectly to death. 
In the present study, ischemia and reperfusion injury, 
evaluated on the basis of serum aminotransferase levels at 5 and 
60 minutes and four hours (1440 minutes) after arterial graft 
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revascularization, was of low intensity in both groups. Ischemia/
reperfusion injury is directly related to prolonged times of ischemia, 
to the quality of the graft, the conditions of the donor, and the 
type of hypothermic preservation. The implantation time was also 
similar for the two groups, demonstrating that the intraoperative 
parameters did not interfere, in general, with postoperative 
outcome. In addition, the postoperative aminotransferase profiles 
did not discriminate between survivors and non-survivors despite 
higher mean ALT and AST levels with a greater dispersion of 
the values among non-survivors, explaining the absence of a 
significant difference between groups. 
Conclusions
No significant difference in the parameters studied was 
detected between the two groups. Under the conditions of the 
present study and regarding the parameters evaluated, no direct 
relation was detected between the intraoperative period and the 
type of patient outcome in the two groups studied.  
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